LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
- Mengxing Li
- , Suryavathi Viswanadhapalli
- , Bindu Santhamma
- , Uday P. Pratap
- , Yiliao Luo
- , Junhao Liu
- , Kristin A. Altwegg
- , Weiwei Tang
- , Zexuan Liu
- , Xiaonan Li
- , Behnam Ebrahimi
- , Hui Yan
- , Yi Zou
- , Swapna Konda
- , Gangadhara R. Sareddy
- , Zhenming Xu
- , Yidong Chen
- , Manjeet K. Rao
- , Andrew J. Brenner
- , Virginia G. Kaklamani
Research output: Contribution to journal › Article › peer-review
20
Link opens in a new tab
Scopus
citations